Taken together, these findings indicate that adiponectin represses the proliferation of epithelial ovarian cancer cells and reverses the stimulatory effects of E2 and IGF-1 on cell proliferation by downregulating the expression of their receptors. The gene discussed is ADIPOQ; the disease is ovarian carcinoma.